BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $20
Benzinga Newsdesk 9 hours ago
Analyst RatingsNewsPrice Target
BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $18 to $20.
BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $18 to $20.